T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model
- 1 June 2015
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 98 (3) , 455-466
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
This publication has 54 references indexed in Scilit:
- Endothelial Cell-Pericyte Interactions Stimulate Basement Membrane Matrix Assembly: Influence on Vascular Tube Remodeling, Maturation, and StabilizationMicroscopy and Microanalysis, 2011
- Erk1 and Erk2 Regulate Endothelial Cell Proliferation and Migration during Mouse Embryonic AngiogenesisPLOS ONE, 2009
- Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006)The American Journal of Pathology, 2006
- Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalizationJournal of Cell Science, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicityToxicology Letters, 2004
- Molecular regulation of vessel maturationNature Medicine, 2003
- Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin PathwayJournal of Biological Chemistry, 2000
- Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during AngiogenesisJournal of Cell Biology, 1998
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990